Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $338.28 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $132.65 | 1 | $0 (2022) |
| ABBVIE INC. | $86.93 | 5 | $0 (2022) |
| PFIZER INC. | $50.55 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $36.23 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.26 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $14.66 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $34.58 | 2 | PFIZER INC. ($19.92) |
| 2022 | $201.32 | 5 | Abbott Laboratories ($132.65) |
| 2021 | $102.38 | 6 | AstraZeneca Pharmaceuticals LP ($36.23) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/30/2022 | Abbott Laboratories | AMPLATZER (Device) | Food and Beverage | In-kind items and services | $132.65 | General |
| Category: Structural Heart | ||||||
| 11/04/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/22/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/07/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/12/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/26/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/22/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/27/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 282 | 476 | $352,079 | $29,038 |
| 2022 | 3 | 236 | 431 | $309,515 | $28,282 |
| 2021 | 5 | 300 | 550 | $401,282 | $36,936 |
| 2020 | 6 | 369 | 605 | $425,249 | $39,923 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 252 | $161,586 | $12,758 | 7.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 111 | 118 | $103,780 | $8,343 | 8.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 106 | $86,714 | $7,938 | 9.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 115 | 305 | $219,452 | $20,323 | 9.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 108 | 113 | $83,521 | $7,408 | 8.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $6,542 | $551.00 | 8.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 144 | 392 | $290,511 | $26,768 | 9.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 111 | 113 | $86,299 | $7,782 | 9.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 20 | 20 | $10,903 | $1,128 | 10.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 14 | 14 | $7,876 | $731.64 | 9.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 11 | 11 | $5,693 | $526.57 | 9.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 147 | 343 | $254,197 | $23,968 | 9.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 126 | 128 | $97,755 | $9,006 | 9.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 48 | 81 | $41,512 | $3,992 | 9.6% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 12 | 17 | $12,684 | $1,223 | 9.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 19 | 19 | $9,833 | $938.20 | 9.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 17 | 17 | $9,268 | $795.70 | 8.6% |
About Madonna Dechristopher, CNP
Madonna Dechristopher, CNP is a Family healthcare provider based in Fairfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023169323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Madonna Dechristopher, CNP has received a total of $338.28 in payments from pharmaceutical and medical device companies, with $34.58 received in 2023. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($338.28).
As a Medicare-enrolled provider, Dechristopher has provided services to 1,187 Medicare beneficiaries, totaling 2,062 services with total Medicare billing of $134,179. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Fairfield, OH
- Active Since 01/15/2007
- Last Updated 09/30/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1023169323
Products in Payments
- AMPLATZER (Device) $132.65
- TEFLARO (Drug) $69.79
- ELIQUIS (Drug) $50.55
- BRILINTA (Drug) $21.34
- STIOLTO RESPIMAT (Drug) $17.26
- AVYCAZ (Drug) $17.14
- LOKELMA (Drug) $14.89
- XARELTO (Drug) $14.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fairfield
Laurie Bresee
Family — Payments: $11,797
Ayisha Ilias, Fnp-C, FNP-C
Family — Payments: $6,729
Mr. Manuel Marquez, Fnp, FNP
Family — Payments: $6,505
Todd Clark, Aprn, APRN
Family — Payments: $4,297
Mr. Stephen Rogers, Fnp-C, FNP-C
Family — Payments: $4,208
Ms. Jillian Ross, A.p.r.n, A.P.R.N
Family — Payments: $3,749